- Home
- PLAG vs RNAZ Comparison
PLAG vs RNAZ Comparison
Compare PLAG & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAG
- RNAZ
- Stock Information
- Founded
- PLAG 1986
- RNAZ 2016
- Country
- PLAG United States
- RNAZ United States
- Employees
- PLAG N/A
- RNAZ N/A
- Industry
- PLAG Packaged Foods
- RNAZ Biotechnology: Pharmaceutical Preparations
- Sector
- PLAG Consumer Staples
- RNAZ Health Care
- Exchange
- PLAG Nasdaq
- RNAZ Nasdaq
- Market Cap
- PLAG 6.6M
- RNAZ 6.1M
- IPO Year
- PLAG N/A
- RNAZ 2021
- Fundamental
- Price
- PLAG $0.87
- RNAZ $7.70
- Analyst Decision
- PLAG
- RNAZ Strong Buy
- Analyst Count
- PLAG 0
- RNAZ 1
- Target Price
- PLAG N/A
- RNAZ $280.00
- AVG Volume (30 Days)
- PLAG 838.0K
- RNAZ 28.9K
- Earning Date
- PLAG 08-13-2025
- RNAZ 08-13-2025
- Dividend Yield
- PLAG N/A
- RNAZ N/A
- EPS Growth
- PLAG N/A
- RNAZ N/A
- EPS
- PLAG N/A
- RNAZ N/A
- Revenue
- PLAG $6,066,143.00
- RNAZ N/A
- Revenue This Year
- PLAG N/A
- RNAZ N/A
- Revenue Next Year
- PLAG N/A
- RNAZ N/A
- P/E Ratio
- PLAG N/A
- RNAZ N/A
- Revenue Growth
- PLAG N/A
- RNAZ N/A
- 52 Week Low
- PLAG $0.47
- RNAZ $6.15
- 52 Week High
- PLAG $5.52
- RNAZ $924.00
- Technical
- Relative Strength Index (RSI)
- PLAG 34.50
- RNAZ 44.89
- Support Level
- PLAG $0.75
- RNAZ $7.50
- Resistance Level
- PLAG $0.94
- RNAZ $8.48
- Average True Range (ATR)
- PLAG 0.34
- RNAZ 0.60
- MACD
- PLAG -0.13
- RNAZ 0.34
- Stochastic Oscillator
- PLAG 13.52
- RNAZ 54.91
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.